UTI Diagnostics: A Practitioner’s Guide to the Testing Landscape

UTI Diagnostics: A Practitioner’s Guide to the Testing Landscape

Independent CPD‑style education for healthcare professionals

Bladder Health UK and Tota are pleased to host this clinician‑focused session exploring the current diagnostic landscape for urinary tract infection. Join Dr Nick Parkinson, PhD, Chief Scientist at Tota for a session designed as independent education on UTI testing methods, to support practitioners working across primary and secondary care.

UTIs remain one of the most common reasons for consultation, antibiotic prescribing and hospital admission, yet diagnostic uncertainty continues to challenge clinicians and patients alike. This session provides a clear, evidence‑based overview of tools available, their limitations, and how to interpret results in real‑world practice.

What this session covers
A walkthrough of the modern UTI testing landscape, including:

• A technical deep dive into dipstick testing, standard culture, EQUC, PCR panels, 16S rRNA sequencing and whole metagenomic sequencing

• A clearer framework for interpreting borderline or ambiguous results, including the asymptomatic debate

• Clinical interpretation challenges, including dysbiosis and asymptomatic bacteriuria 

• An understanding of the vaginal-urinary microbiome relationship and its relevance to recurrent and chronic UTI

• Practical framing for discussing lab testing options with patients 

• Why correlating lab findings with patient symptoms remains essential

Evidence base
This session draws on peer‑reviewed research and national surveillance data, including:

• Butler CC et al. British Journal of General Practice (2015)

• UK Health Security Agency. Understanding the burden of UTI hospitalisations in England (2025)

• Dolk F et al. Journal of Antimicrobial Chemotherapy (2018)